⌘K

Login Start Free

Home/Filings/4/0001418919-08-000001

4//SEC Filing

MURPHY JAMES R 4

Accession 0001418919-08-000001

CIK 0001418919other

View on SEC.gov Company Profile

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 2:51 PM ET

Size

8.8 KB

Accession

0001418919-08-000001

Insider Transaction Report

Form 4

Period: 2008-07-22

CPEX Pharmaceuticals, Inc.CPEX

Director

Transactions

Exercise/Conversion
Restricted Stock Units
2008-07-22−2,700→ 0 total
Exercise: $0.00Exp: 2008-07-22→ Common Stock, $0.01 par value (2,700 underlying)
Exercise/Conversion
Common Stock, $0.01 par value
2008-07-22+2,700→ 45,590 total

Holdings

Common Stock, $0.01 par value
(indirect: By son)
10
Common Stock, $0.01 par value
(indirect: By 401(k))
1,211

Footnotes (2)

[F1]One restricted stock unit represents the right to receive one share of CPEX common stock, $0.01 par value.
[F2]The vesting and settlement of these awards was accelerated upon the termination of the reporting person's employment with Bentley Pharmaceuticals, Inc. following the closing of its acquisition by Teva Pharmaceutical Industries Ltd. on July 22, 2008.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

CPEX Pharmaceuticals, Inc.

CIK 0001418919

Entity typeother

Related Parties

1

filerCIK 0001218893

Filing Metadata

Form type: 4
Filed: Jul 24, 8:00 PM ET
Accepted: Jul 25, 2:51 PM ET
Size: 8.8 KB

View on SEC.gov